MAO Wenjuan. Efficacy and safety of β-blocker in the treatment of patients with heart failure and atrial fibrillation[J]. Journal of Clinical Medicine in Practice, 2019, (2): 33-36. DOI: 10.7619/jcmp.201902010
Citation:
|
MAO Wenjuan. Efficacy and safety of β-blocker in the treatment of patients with heart failure and atrial fibrillation[J]. Journal of Clinical Medicine in Practice, 2019, (2): 33-36. DOI: 10.7619/jcmp.201902010
|
MAO Wenjuan. Efficacy and safety of β-blocker in the treatment of patients with heart failure and atrial fibrillation[J]. Journal of Clinical Medicine in Practice, 2019, (2): 33-36. DOI: 10.7619/jcmp.201902010
Citation:
|
MAO Wenjuan. Efficacy and safety of β-blocker in the treatment of patients with heart failure and atrial fibrillation[J]. Journal of Clinical Medicine in Practice, 2019, (2): 33-36. DOI: 10.7619/jcmp.201902010
|